1ludici M, Cuomo G, Vettori S, et al. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis ( SSc-ILD ) : Efficacy of maintenance immunosuppression in responders and non-re- spenders[ J]. Semin Arthritis Rheum ,2014,172 (14) :219 - 222. 被引量：1
2Caramaschi P, Dalla GA, Prati D, et al. Severe vascular complications in patients affected by systemic sclerosis cyclically treated with iloprost [ J ]. Rheumatol Int ,2012,32 (7) : 1933 - 1938. 被引量：1
3Schuster J, Moinzadeh P, Kurschat C, et al. Proteinuria in systemic scle- rosis:reversal by ACE inhibition [ J ]. Rheumatol Int, 2013,33 ( 9 ) : 2225 - 2230. 被引量：1
4Murdaca G, Spano F, Contatore M, et al . Potential use of TNF-α inhibi- tors in systemic sclerosis [ J ]. Immuntherapy,2014,6 ( 3 ) :283 - 289. 被引量：1
5Fraticelli P, Gabrielli B, Pompenio G, et al. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide : a phase II pilot study [ J ]. Arthritis Res Ther, 2014, 16(4) :R144. 被引量：1
6Vaz CP,Almeida I, Guedes M, et al. Autologous Stem Cell Transplanta- tion in a patient with severe Systemic sclerosis[J]. Acta Reumatol Port, 2014,39( 3 ) :262 - 264. 被引量：1
7Takagi G, Miyemoto M, Tara S, et al. Therapeutic vascular angiogenesis for intractable macroangiopathy-related digital ulcer in patients with sys- temic sclerosis : a pilot study [ J ]. Rheumatology (Oxford) ,2014,53 ( 5 ) : 854 - 859. 被引量：1
8Bene MD,Pozzi MR,Rovati L,et al. Autologous Fat Grafting for Sclero- derma-Induced Digital Ulcers. An Effective Technique in Patients with Systemic Sclerosis [ J ]. Handchir Mikrochir Plast Chit, 2014,46 (4) : 242 - 247. 被引量：1
9Papp G, Horvath IF, Barath S, et al. Immunomodulatory effects of extra- corporeal photochemotherapy in systemic sclerosis [ J ]. Clin Immunol, 2012,142(2) :150 - 159. 被引量：1
10Tsou PS, Balogh B, Pinney A J, et al. Lipoic acid plays a role in sclero- derma:insights obtained from scleroderma dermal fibroblasts [ J ]. Ar- thritis Res Ther,2014,16(5) :411. 被引量：1
2Ishikawa H, Takeda K, Okamoto A, et al. Induction of autoimmu- nity in a blcomycin-induced routine model of experimental systemic sclerosis: an important role for CD4 + T cells[J]. J Invest Derma- tol, 2009,129 (7) : 1688-1695. 被引量：1
3Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[ J ]. Nat Immunol, 2005,6( 11 ) :1133-1141. 被引量：1
4Varga J, Abraham D. Systemic sclerosis: a prototypie multisystem fibrotic disorder[ J]. J Clln Invest, 2007,117 (3) :557-567. 被引量：1
5Yamamoto T, Nishioka K. Role of monocyte chemoattractant pro- tein-1 and its receptor, CCR-2, in the pathogenesis of bleomycin- induced scleroderma [ J ]. J Invest Dermatol, 2003, 121 ( 3 ) : 510-516. 被引量：1
6Chizzolini C. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis [ J ]. Curt Opin Rheumatol, 2008,20 (6) :707 -712. 被引量：1
7Barnes TC, Anderson ME, Moots RJ. The many faces of interleu- kin-6 : the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis[J]. Int J P,.heumatol, 2011,2011:721608. 被引量：1
8Ogura H, Murakami M, Okuyama Y, et al. Interleukin-17 pro- motes autoimmunity by triggering a positive-feedback loop via inter- leukin-6 induction[J]. Immunity, 2008,29(4):628-636. 被引量：1
